We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Naturally Derived Plant Compounds Protect Skin during Cancer Radiotherapy

By LabMedica International staff writers
Posted on 06 Aug 2014
Plant-derived natural compounds may provide protection to the skin from the damaging effects of gamma radiation during cancer radiotherapy, according to new research.

Radiotherapy for cancer involves exposing the patient or their tumor more directly to ionizing radiation, such as X-rays or gamma rays. More...
The radiation irreparably injures the cancer cells. Regrettably, such radiation is also harmful to healthy tissue, in particular, the skin over the site of the tumor, which is then at risk of hair loss, skin problems, and even skin cancer. Because of these disadvantages, finding ways to protect the overlying skin are being actively sought.

Writing in the August/September 2014 issue of the International Journal of Low Radiation, Dr. Faruck Lukmanul Hakkim, from the University of Nizwa (Oman) and Nagasaki University (Japan), and colleagues from Macquarie University (Sydney, NSW, Australia), Bharathiar University (Coimbatore, Tamil Nadu, India) and Konkuk University (Seoul, Republic of Korea), explained how three abundant and well-evaluated natural products derived from plants can protect the skin against gamma radiation during radiotherapy.

Dr. Hakkim and colleagues discussed in their article the benefits of the organic, antioxidant compounds caffeic acid (CA), rosmarinic acid (RA), and trans-cinnamic acid (TCA) used at nontoxic concentrations. They assessed the radio-protective effect of these compounds against gamma-radiation in terms of reducing levels of reactive oxygen species (ROS) generated in skin cells by clinical relevance dose of gamma ray in the laboratory and in terms of the damage to the genetic material DNA, specifically double strand breaks in laboratory samples of human skin cells (keratinocytes).

The investigators discovered that treating the human skin cells with CA, RA, and TCA can protect the cells by 40, 20, and 15%, respectively, from gamma ray toxicity. The scientists suggested that the protective effect occurs because the compounds soak up the ROS and chemically deactivate them as well as enhancing the body’s natural DNA repair processes.

The investigators suggested that these compounds would be well-suited to be used as skin protectants during combination chemo- and radiotherapy. Further research is ongoing to study the clinical potential of mixtures of the three natural products.

Related Links:

University of Nizwa
Nagasaki University
Macquarie University



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.